On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B

doi:10.3748/wjg.v25.i32.4764

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7269)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

498

WORD

248

HTML

3917

Figures (1-6)

168

Tables (1-2)

146

Sum=4977

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

734

Download

1558

Sum=2292

Aug 28, 2019 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Aug 28, 2019; 25(32): 4764-4778
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4764

Full Size Figure Download Figure

Figure 4 Variables associated with hepatic fibrosis. Odds of Ishak fibrosis score 3-6 by multiple ordinal logistic regression for the whole patient. HBcrAg: Hepatitis B core-related antigen; OR: Odds rate; CI: Confidence interval.

Citation: Chang XJ, Sun C, Chen Y, Li XD, Yu ZJ, Dong Z, Bai WL, Wang XD, Li ZQ, Chen D, Du WJ, Liao H, Jiang QY, Sun LJ, Li YY, Zhang CH, Xu DP, Chen YP, Li Q, Yang YP. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B. World J Gastroenterol 2019; 25(32): 4764-4778
URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4764.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i32.4764